ReviewTropical diseases, travel medicine and vaccines2020
Recommendations for the adjuvant use of the poly-antibiotic-resistant probiotic
Review in Tropical diseases, travel medicine and vaccines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 23 citations in OpenAlex.
- Efficacy of probiotic-supplemented formula in treating chronic diarrhea in children aged 6-43 months: evidence based on a randomized controlled trial.Gut pathogens · 2026Article
- Risk Factors for Antibiotic-Associated Diarrhoea in Paediatric Patients With Severe Pneumonia: A Retrospective Cohort.Nursing in critical care · 2026Article
- Effectiveness ofAntibiotics (Basel, Switzerland) · 2025Review
- Effect of the ProbioticVeterinary sciences · 2023Article
- Effect ofContemporary clinical trials communications · 2023Article
- HPLC-MS-MS quantification of short-chain fatty acids actively secreted by probiotic strains.Frontiers in microbiology · 2023Article
- Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review.Advances in therapy · 2022Review
- Current Progress and Future Perspectives on the Use of Bacillus clausiiMicroorganisms · 2022Review
- Efficacy and safety of Bacillus clausii (O/C, N/R, SIN, T) probiotic combined with oral rehydration therapy (ORT) and zinc in acute diarrhea in children: a randomized, double-blind, placebo-controlled study in India.Tropical diseases, travel medicine and vaccines · 2022Article
- Bacteremia after Bacillus clausii administration for the treatment of acute diarrhea: A case report.Biomedica : revista del Instituto Nacional de Salud · 2021Article
- Therapeutic efficacy of probioticHeliyon · 2021Article
- Current understanding of antibiotic-associated dysbiosis and approaches for its management.Therapeutic advances in infectious diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 10 institutions in 6 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper proposes recommendations for probiotics in pediatric gastrointestinal diseases in the Asia-Pacific region. Evidence-based recommendations and randomized controlled trials in the region are included. Cultural aspects, health management issues and economic factors were also considered. Final recommendations were approved by utilizing a modified Delphi process and applying the Likert scale in an electronic voting process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.